Want to see SRTA full AI Analyst Report?

Strata Critical Medical (SRTA) Price & Analysis

1,022 Followers

SRTA Stock Chart & Stats

$6.19

-$0.05(-0.98%)

At close: Jul 24 4:00 PM EDT

$6.19

-$0.05(-0.98%)

Day’s Range― - ―

52-Week Range$3.95 - $6.50

Previous CloseN/A

Volume1.08M

Average Volume (3M)779.73K

Market Cap

$452.07M

Enterprise Value$435.59

Total Cash (Recent Filing)$22.75M

Total Debt (Recent Filing)$4.25M

Price to Earnings (P/E)9.8

Beta2.14

Next Earnings

Nov 11, 2026

EPS Estimate

>-0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.24

Shares Outstanding88,466,805

10 Day Avg. Volume713,832

30 Day Avg. Volume779,729

Financial Highlights & Ratios

PEG Ratio-0.04

Price to Book (P/B)1.42

Price to Sales (P/S)2.01

P/FCF Ratio-6.62

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price Target

$9.50

Price Target Upside53.47% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-0.03

Revenue Forecast (FY)$276.93M

Bulls Say, Bears Say

Bulls Say

Clinical Revenue GrowthRapid clinical revenue growth, including strong organic expansion, indicates increasing adoption of the company’s services. Clinical’s rising contribution can support a more favorable revenue mix and provide a durable growth engine as transplant-related demand expands.

Conservative Balance SheetVery low leverage and a substantial equity cushion give Strata financial flexibility to fund operations, pursue acquisitions, and absorb volatility without relying heavily on external borrowing. This conservative balance sheet also reduces refinancing pressure as the company scales.

Raised Growth GuidanceHigher full-year revenue and adjusted EBITDA guidance signals that management sees stronger underlying demand and improved earnings capacity. The revised outlook, alongside planned clinical expansion and acquisitions, supports a constructive multi-quarter growth trajectory.

Bears Say

Persistent Negative Cash FlowThe extended history of negative operating and free cash flow shows that reported earnings have not consistently converted into internally generated liquidity. Until this improves, Strata may need balance-sheet resources to support investment and ongoing operations.

Weak Core Operating ProfitabilityNegative EBIT and EBITDA indicate that core operations have not yet produced consistent operating earnings, even though net income has turned positive. This raises questions about margin quality and the sustainability of reported profitability during continued expansion.

Logistics Margin And Volume PressureReduced customer volume and weaker Logistics margins create a meaningful execution challenge while the segment remains part of the business base. The pressure may persist for one to two quarters, requiring new wins and operational improvements to restore growth.

Strata Critical Medical News

Strata Critical Medical management to meet with Craig-Hallum

Meeting to be held in Minneapolis on August 11-12 hosted by Craig-Hallum. Published first on TheFly – the...

2M ago

SRTA

Strata Critical Medical Q2 Call Signals Clinical Upswing

Strata Critical Medical, Inc. (($SRTA)) has held its Q2 earnings call. Read on for the main highlights of...

2M ago

SRTA

Strata Critical Medical, Inc. (SRTA) Q2 Earnings Cheat Sheet

Strata Critical Medical, Inc. (SRTA) is scheduled to report 2nd quarter earnings on 08/04/2026, before the market opens....

2M ago

SRTA

Cathie Wood Loads Up on Tesla and SoFi Ahead of Holiday Break, Trims Roku and Biotech Stocks

Cathie Wood’s ARK Invest headed into the Independence Day holiday with another round of major portfolio changes. According...

3M ago

BLSH

ROKU

Cathie Wood Defies Market Selloff: Invests $64M in SpaceX and Roblox on Huge Single-Day Drops

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio moves on Monday, June 22. The firm bought more Space...

3M ago

ALMR

LLY, COIN, HOOD, and ROKU Stocks in Focus: Cathie Wood Sells Winners and Buys New Catalysts — 6/18/26

ARK’s daily trade report for June 17 showed Cathie Wood moving capital across several high-profile names. The firm...

4M ago

LLY

XYZ

Strata Critical Medical management to meet with B. Riley

Meeting to be held in Canada on June 22-23 hosted by B. Riley. Published first on TheFly –...

4M ago

SRTA

Strata Critical Medical shareholders back directors and governance items

The latest announcement is out from Strata Critical Medical ( ($SRTA) ). On May 28, 2026, Strata Critical...

4M ago

SRTA

Strata Critical Medical price target raised to $11.50 from $11.25 at Ladenburg

Ladenburg analyst Jon Hickman raised the firm’s price target on Strata Critical Medical (SRTA) to $11.50 from $11.25...

5M ago

SRTA

Strata Critical Medical reports Q1 EPS 3c, consensus (4c)

Reports Q1 revenue $67.38M, consensus $63.67M. “We are pleased to report Q1 results that came in ahead of...

5M ago

SRTA

Strata Critical Medical backs FY26 revenue view $260M-$275M, consensus $269.18M

Backs FY26 adjusted EBITDA view $29M-$33M. “The underlying strength of our transformed economic model is finally shining through...

5M ago

SRTA

Blade Air Mobility Earnings Call Highlights Growth, Volatility

Blade Air Mobility, Inc. (($SRTA)) has held its Q1 earnings call. Read on for the main highlights of...

5M ago

SRTA

Strata Critical Medical management to meet virtually with Lake Street

Virtual Meeting to be held on May 12 hosted by Lake Street. Published first on TheFly – the...

5M ago

SRTA

Cathie Wood Sells Strata Critical Medical (SRTA), but Top Analysts See 120% Upside in This Penny Stock. Here’s Why

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made one notable portfolio move on Monday, April 13. The ace hedge fund...

6M ago

SRTA

SRTA FAQ

What was Strata Critical Medical’s price range in the past 12 months?

Strata Critical Medical lowest stock price was $3.95 and its highest was $6.50 in the past 12 months.

What is Strata Critical Medical’s market cap?

Strata Critical Medical’s market cap is $452.07M.

When is Strata Critical Medical’s upcoming earnings report date?

Strata Critical Medical’s upcoming earnings report date is Nov 11, 2026 which is in 40 days.

How were Strata Critical Medical’s earnings last quarter?

Strata Critical Medical released its earnings results on Aug 04, 2026. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.02 by -$0.1.

Is Strata Critical Medical overvalued?

According to Wall Street analysts Strata Critical Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Strata Critical Medical pay dividends?

Strata Critical Medical does not currently pay dividends.

What is Strata Critical Medical’s EPS estimate?

Strata Critical Medical’s EPS estimate is >-0.01.

How many shares outstanding does Strata Critical Medical have?

Strata Critical Medical has 88,466,805 shares outstanding.

What happened to Strata Critical Medical’s price movement after its last earnings report?

Strata Critical Medical reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.02. Following the earnings report the stock price went up 0.36%.

Which hedge fund is a major shareholder of Strata Critical Medical?

Currently, no hedge funds are holding shares in SRTA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Strata Critical Medical Stock Smart Score

Underperform

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

28.99%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Strata Critical Medical

Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.

Strata Critical Medical (SRTA) Earnings & Revenues

Historic Earnings Reports

SRTA Company Deck

SRTA Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call presents a largely positive picture driven by robust clinical growth, accretive bolt-on acquisitions, stronger-than-expected revenue and raised full-year guidance, and consecutive quarters of cash generation. These positives are tempered by near-term softness in Logistics (a ~3% revenue headwind from one customer), margin pressure from fuel pass-through mechanics and maintenance, and working-capital/transaction-related cash drag. Management provided concrete mitigation plans for Logistics margins and expects recovery in the back half of the year, supporting a constructive outlook.View all SRTA earnings summaries

SRTA Stock 12 Month Forecast

Average Price Target

$9.50

▲(53.47% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","10":"$10","4.75":"$4.75","6.5":"$6.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$9.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,4.75,6.5,8.25,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.83,5.189230769230769,5.548461538461538,5.907692307692308,6.266923076923077,6.626153846153846,6.985384615384616,7.344615384615385,7.703846153846154,8.063076923076924,8.422307692307692,8.781538461538462,9.14076923076923,{"y":9.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.83,5.189230769230769,5.548461538461538,5.907692307692308,6.266923076923077,6.626153846153846,6.985384615384616,7.344615384615385,7.703846153846154,8.063076923076924,8.422307692307692,8.781538461538462,9.14076923076923,{"y":9.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.83,5.189230769230769,5.548461538461538,5.907692307692308,6.266923076923077,6.626153846153846,6.985384615384616,7.344615384615385,7.703846153846154,8.063076923076924,8.422307692307692,8.781538461538462,9.14076923076923,{"y":9.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.16,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.03,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.19,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.81,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.72,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.49,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.18,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.28,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.02,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.37,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.83,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >